Search for: All records

Abstract On 5 April 2024, 10:23 a.m. local time, a moment magnitude 4.8 earthquake struck Tewksbury Township, New Jersey, about 65 km west of New York City. Millions of people from Virginia to Maine and beyond felt the ground shaking, resulting in the largest number (>180,000) of U.S. Geological Survey (USGS) “Did You Feel It?” reports of any earthquake. A team deployed by the Geotechnical Extreme Events Reconnaissance Association and the National Institute of Standards and Technology documented structural and nonstructural damage, including substantial damage to a historic masonry building in Lebanon, New Jersey. The USGS National Earthquake Information Center reported a focal depth of about 5 km, consistent with a lack of signal in Interferometric Synthetic Aperture Radar data. The focal mechanism solution is strike slip with a substantial thrust component. Neither mechanism’s nodal plane is parallel to the primary northeast trend of geologic discontinuities and mapped faults in the region, including the Ramapo fault. However, many of the relocated aftershocks, for which locations were augmented by temporary seismic deployments, form a cluster that parallels the general northeast trend of the faults. The aftershocks lie near the Tewksbury fault, north of the Ramapo fault. 

Abstract Open and practical exchange, dissemination, and reuse of specimens and data have become a fundamental requirement for life sciences research. The quality of the data obtained and thus the findings and knowledge derived is thus significantly influenced by the quality of the samples, the experimental methods, and the data analysis. Therefore, a comprehensive and precise documentation of the pre‐analytical conditions, the analytical procedures, and the data processing are essential to be able to assess the validity of the research results. With the increasing importance of the exchange, reuse, and sharing of data and samples, procedures are required that enable cross‐organizational documentation, traceability, and non‐repudiation. At present, this information on the provenance of samples and data is mostly either sparse, incomplete, or incoherent. Since there is no uniform framework, this information is usually only provided within the organization and not interoperably. At the same time, the collection and sharing of biological and environmental specimens increasingly require definition and documentation of benefit sharing and compliance to regulatory requirements rather than consideration of pure scientific needs. In this publication, we present an ongoing standardization effort to provide trustworthy machine‐actionable documentation of the data lineage and specimens. We would like to invite experts from the biotechnology and biomedical fields to further contribute to the standard.